DUBLIN--(BUSINESS WIRE)--The "Targeted Oncology Therapeutics: Therapeutics, Markets, Players and Forecasts" report has been added to ResearchAndMarkets.com's offering.
A number of factors are changing the way market participants view the cancer therapeutics market. These factors are evident in the disease targets and drug classes that comprise a significant number of recent trials.
After decades of disappointment and missed financial objectives, the genetic underpinnings of disease are converging with improved computer-assisted pharmacological decision making. Market sector participants now find themselves pursuing realistic therapeutic strategies that have the potential to fulfill product strategies in both scientific and human terms.
What You Will Learn
- What is the market share of approved therapeutics?
- What is the global supply picture for targeted therapeutics?
- Who are the market leaders, by Indication? by Product?
- What is the therapeutic coverage across all oncology indications? What are the product opportunities?
- What are the established products in this space? by target, indication, API class, revenue?
-
What is the competitive picture for the major Oncology market segments?
- Drug treatment resources
- Competitive therapy map
- Clinical trial activity
-
Who are the leading competitors in the field of next-generation therapeutics?
Key Topics Covered:
- Executive Summary
- The Recombinant Drug Ecosystem
- Targeted Oncology Therapeutics Market Leaders
- Oncology Biologics - Competitive Considerations
- Approved Drugs for targeted Oncology Therapeutics
- FDA-approved Drugs
- EMA-approved Drugs
- Biosimilars of Trastuzumab
- EMA Approved Biosimilars
- The Impact of Litigation on Biosimilar Product Launches
- Target Oncology Therapeutics - Market Segments
- Breast Cancers
- Colorectal Cancers
- Hematology Cancers
- Lung Cancers
- Melanomas
- Metastatic Gastric Cancers
- Neurological Cancers
- Renal Cell Carcinomas
- Urothelial Cancers
- Supplier Competitive Assessments
For more information about this report visit https://www.researchandmarkets.com/r/pizply
